Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 30, 2024GSC Biological and Pharmaceutical SciencesOpen Access

Costs and affordability of psychotropic medicines for patients with schizophrenia in Nigeria

View Full Paper
Ask AI
Bookmark
Share

Authors

AOAmala Chukwunwike OforEnugu State University of Science and TechnologyOEObinna Ikechukwu EkwunifeNnamdi Azikiwe UniversityBOB OgbonnaNnamdi Azikiwe University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ofor et al. (2024) studied this question.

synapsesocial.com/papers/68e5e7feb6db64358757c75dhttps://doi.org/10.30574/gscbps.2024.28.1.0231
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Barriers to care among people with schizophrenia attending a tertiary psychiatric hospital in Nigeria2019 · 17 citations
  2. 2Prevalence and economic burden of polypharmacy in a secondary healthcare facility in North-Central Nigeria: a cross-sectional study2026
  3. 3Determinants of Psychotic Relapse in Patients with Schizophrenia: A Cross-Sectional Study at the Federal Medical Center, Gusau, Zamfara State2026
  4. 4Analyzing the direct medical cost of Schizophrenia in Hospital Pulau Pinang, Malaysia2026
  5. 5REAL-WORLD OUTCOMES, SAFETY AND DETERMINANTS OF PSYCHOTROPIC MEDICATION USE AMONG PEOPLE LIVING WITH HIV/AIDS IN THE NIGER DELTA, NIGERIA: A CROSS-SECTIONAL ANALYSIS2026